14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $143.51 $159.34 Wednesday, 24th Apr 2024 ALNY stock ended at $143.80. This is 1.55% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.76% from a day low at $143.52 to a day high of $147.49.
90 days $143.51 $188.69
52 weeks $143.51 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Jul 13, 2021 $176.03 $178.68 $174.67 $175.63 429 297
Jul 12, 2021 $177.00 $180.24 $176.36 $177.03 907 031
Jul 09, 2021 $173.43 $177.60 $171.65 $176.74 653 281
Jul 08, 2021 $170.16 $172.75 $169.00 $172.50 364 077
Jul 07, 2021 $175.82 $176.00 $170.22 $172.59 358 073
Jul 06, 2021 $172.26 $175.41 $168.68 $174.38 669 511
Jul 02, 2021 $169.49 $172.14 $167.01 $171.43 338 939
Jul 01, 2021 $169.70 $170.06 $166.16 $169.75 492 419
Jun 30, 2021 $165.41 $173.91 $163.29 $169.52 651 285
Jun 29, 2021 $166.90 $167.16 $164.51 $165.87 756 187
Jun 28, 2021 $155.14 $168.34 $154.02 $166.20 2 043 187
Jun 25, 2021 $174.13 $176.75 $172.65 $175.39 912 265
Jun 24, 2021 $176.31 $176.97 $172.86 $173.68 789 326
Jun 23, 2021 $171.82 $175.76 $171.82 $174.63 527 354
Jun 22, 2021 $171.40 $173.13 $168.51 $172.95 721 099
Jun 21, 2021 $175.86 $175.86 $169.70 $171.26 1 059 469
Jun 18, 2021 $171.08 $177.53 $169.97 $176.89 1 522 001
Jun 17, 2021 $167.92 $172.53 $167.92 $172.25 627 129
Jun 16, 2021 $166.45 $168.37 $164.94 $168.30 707 264
Jun 15, 2021 $166.50 $168.78 $165.49 $166.50 981 515
Jun 14, 2021 $165.42 $167.37 $164.05 $166.66 820 657
Jun 11, 2021 $161.76 $165.33 $161.76 $165.02 709 382
Jun 10, 2021 $158.01 $163.29 $156.85 $163.26 647 900
Jun 09, 2021 $152.25 $157.50 $151.31 $157.41 648 814
Jun 08, 2021 $152.00 $153.25 $149.98 $151.08 470 538
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT